November 27, 2022

The executive govt of pharmaceutical large Pfizer says his corporate does now not have plans to take a position additional in Russia, as that country’s invasion of Ukraine is ready to go into its 3rd week. 

Nonetheless, CEO Albert Bourla informed “Face the Country” moderator Margaret Brennan that Pfizer isn’t reducing ties with Russia totally, and famous that whilst the corporate makes “some medications in Russia for Russia,” the corporate does now not export from Russia. 

image-from-ios-6.jpg
Pfizer CEO Richard Bourla is interviewed through “Face the Country” moderator Margaret Brennan.

display shot


Bourla identified that industry restrictions frequently exempt lifesaving prescribed drugs for humanitarian causes.

“How are you able to say I am not going to ship the most cancers medications to Russians as a result of what they did,” Bourla stated. 

Up to now two weeks, a string of Western companies have curtailed operations in Russia or withdrawn from Russian markets altogether. Starbucks, McDonalds and Coca-Cola introduced this week they’d pull again. 

Bourla additionally stated that the corporate’s publicity in Russia is restricted, and that any monetary fallout from the battle might be “very minimum” to Pfizer’s final analysis. Lower than part a p.c of the corporate’s general earnings comes from Russia, Bourla stated.

He informed Brennan that he does now not be expecting provide chain delays or any value drive to outcome from the battle. 

“We’re very unbiased in the case of our supplying our elements from the ones portions of the arena,” Bourla stated. “We don’t be expecting to peer on the earth any disruptions, presently a minimum of, as a result of this battle.”

See also  Russia to annex 4 occupied areas of Ukraine this week after "referendums" staged through Moscow